Key Takeaways: TRT after 50 follows the same principles as TRT at any age — replace into the normal range, monitor labs, adjust by trough levels — but the dial settings change. Older men often need lower starting doses (60-100 mg/week vs 120-140 mg/week typical for younger men), tighter hematocrit ceilings, and more frequent PSA checks. The TRAVERSE trial in 5,246 men aged 45-80 found no excess cardiovascular or prostate cancer risk vs placebo when levels were replaced into the normal range. Age is not a contraindication. Protocol drift is.
How TRT Changes After 50
Testosterone naturally declines about 1-2% per year after age 30. By 50, total testosterone is roughly 20-30% lower than it was at 25 for the average man. SHBG often rises with age, binding more of what remains, which means free testosterone — the bioavailable fraction — falls faster than total.
That is the biology. The clinical picture changes too:
Hematocrit rises more readily. Older men hit the 52% red-cell ceiling at lower TRT doses than men in their 30s. This is the single most common dose-limiting side effect after 50.
Prostate monitoring matters more. PSA tends to drift up with age regardless of TRT. A baseline PSA and digital rectal exam before starting matter more in this population.
Cardiovascular comorbidities are more common. Hypertension, dyslipidemia, and subclinical sleep apnea are background risks that TRT can interact with — usually neutrally, sometimes amplifying.
Recovery is slower. Symptom resolution takes the same trajectory — libido at 4-8 weeks, energy and mood at 8-12, body composition at 6-12 months — but the absolute gains are typically smaller than in younger men.
None of this makes TRT inappropriate after 50. It just means the protocol needs to fit the patient, not the textbook for a 35-year-old.
What the Evidence Actually Says
The two biggest data sets in older men:
The Testosterone Trials (T-Trials), 2016. 790 men aged 65+ with low total testosterone (under 275 ng/dL) and symptoms. One year of TRT gel raising T into the normal range produced modest improvements in sexual function, mood, walking distance, and anemia. Bone density improved. Cognitive benefits were not significant.
TRAVERSE, 2023. 5,246 men aged 45-80 with low testosterone and pre-existing or high cardiovascular risk. TRT vs placebo over a mean 22 months showed no significant difference in major adverse cardiovascular events. Prostate cancer rates were similar. The trial answered the long-standing cardiovascular safety question that the FDA had flagged after older retrospective signals — and the answer was that replacement-dose TRT is not cardiovascularly harmful in this population. See the TRAVERSE trial breakdown for the full design and findings.
What both trials underline: TRT works in older men when dosed conservatively into the normal range and monitored properly. The risks that show up in the data are dose- and monitoring-dependent, not age-dependent in a categorical way.
Dose Ranges That Fit Men Over 50
The same dosing principles apply — start conservative, titrate by trough labs at 6-8 weeks, target a free testosterone in the upper-mid normal range — but the typical range shifts down.
Profile
Weekly Dose
Frequency
Target Trough Total T
Target Trough Free T
Starting dose, age 50-65
60-100 mg
2x/week
500-800 ng/dL
12-20 pg/mL
Maintenance, age 50-65
80-140 mg
2x/week
600-900 ng/dL
15-22 pg/mL
Starting dose, age 65+
50-80 mg
2x/week
450-700 ng/dL
12-18 pg/mL
Maintenance, age 65+
60-120 mg
2x/week
500-800 ng/dL
13-20 pg/mL
A few things this chart doesn't capture:
SHBG matters more here. Many older men have higher SHBG. They need higher total T to hit a usable free T. Some have low SHBG and respond strongly to small doses — those men often need EOD or daily microdosing to avoid free T peaks. See the low SHBG TRT protocol for the underlying logic.
Twice-weekly is the default for a reason. Once-weekly produces bigger peaks. Bigger peaks accelerate hematocrit and aromatization. Splitting the same weekly mg into two injections is one of the cleanest ways to reduce side-effect risk without losing efficacy. The injection frequency comparison walks through the pharmacokinetics.
Subcutaneous is increasingly the choice for older men. Smaller needles, less injection-site irritation, similar pharmacokinetics. Detailed in subcutaneous vs intramuscular TRT.
Bloodwork is the difference between TRT going well and TRT going sideways. After 50, the watch list expands.
Baseline (Before Starting)
Total testosterone, free testosterone, SHBG, estradiol (sensitive assay)
CBC with hematocrit
Comprehensive metabolic panel (kidney, liver)
Lipid panel
PSA (men 50+, or 45+ with family history)
Hemoglobin A1c
Blood pressure (resting, two separate readings)
This is more than most younger TRT patients get. After 50 it is the standard of care. A clinic that skips PSA or hematocrit before starting is cutting corners. See questions to ask a TRT clinic for the questions that flag corner-cutting.
6-8 Week Recheck
Trough total T and free T (drawn just before next injection)
Estradiol
Hematocrit
PSA if it rose more than 1.0 ng/mL on baseline
First-Year Monitoring
Every 3 months: hematocrit, total + free T, estradiol, blood pressure
Every 6 months: PSA, lipid panel, comprehensive metabolic panel
Hematocrit climbs with TRT — moderately for most men, sharply for some. After 50, the climb is faster and the ceiling lower. A hematocrit above 52% raises blood viscosity and is the most common reason older men reduce their TRT dose.
What pushes hematocrit up faster:
Higher peak-to-trough doses (once-weekly worse than EOD)
Underlying sleep apnea (often undiagnosed)
Smoking
Dehydration
Higher starting hemoglobin
What to do if hematocrit climbs:
Reduce dose by 10-20 mg/week or split into more frequent injections
Get a sleep study if you snore, have witnessed apneas, or wake unrefreshed
Hydrate aggressively
If hematocrit stays above 54%, therapeutic phlebotomy
TRT does not cause prostate cancer in men without a prior history — that is the modern consensus from TRAVERSE, the Endocrine Society, the BSSM, and multiple meta-analyses. But TRT can:
Raise PSA modestly (typically 0.3-0.5 ng/mL within the first year)
Increase prostate volume slightly, sometimes worsening urinary symptoms in men with pre-existing BPH
Unmask an existing but undetected cancer by raising PSA into a range that triggers biopsy
This is why baseline PSA and a follow-up PSA at 6 months and 12 months matter. A PSA velocity above 0.75 ng/mL per year, or any single reading above 4.0 ng/mL, warrants a urology referral. See testosterone and prostate cancer myths for the evidence walk-through.
For men with treated prostate cancer (post-prostatectomy or post-radiation, stable PSA), TRT is increasingly considered an option after careful evaluation — the SPIRIT trial data is the cleanest source here.
Cardiovascular Interactions
The TRAVERSE trial settled the broad cardiovascular safety question for older men: TRT at replacement doses did not increase MACE versus placebo. But it found:
A small increase in atrial fibrillation
A small increase in pulmonary embolism
No increase in MI, stroke, or cardiovascular death
The practical takeaway for men over 50: if you have a history of AFib, a clotting disorder, or untreated severe sleep apnea, those need to be addressed before or alongside TRT, not ignored. Blood pressure deserves close monitoring — TRT can nudge it up by 3-5 mmHg in some men, more in salt-sensitive men. The TRT blood pressure article covers management.
Estradiol: Different Calculus Over 50
Younger men on TRT sometimes get prescribed aromatase inhibitors reflexively. After 50, crashed estradiol is arguably the bigger problem. Low E2 in older men:
Worsens joint pain and stiffness
Accelerates bone density loss (the opposite of what TRT should do)
Worsens lipid profiles
Often kills libido more than high E2 does
If you are over 50 and your prescriber wants to start you on anastrozole at the same time as testosterone, that is a yellow flag. Most older men do better with the dose dialed in first, AI considered only if estradiol is symptomatic and confirmed elevated on a sensitive assay. The aromatase inhibitor primer and estradiol management on TRT cover the nuance.
What to Expect on the Timeline
The order of returns is similar across ages — but the magnitude is usually smaller and the timeline is slightly longer in older men.
Window
What Usually Improves
Week 2-4
Energy, morning erections, mood
Week 6-12
Libido, motivation, cognition, mild strength gain
Month 3-6
Body composition (lean mass up 2-4 lb, fat mass down 2-4 lb on average)
Month 6-12
Bone density, insulin sensitivity, lipid changes
Month 12+
Cardiovascular markers, hematocrit plateau, full body recomp
The TRT results timeline breaks each stage down. For older men, the realistic expectation is meaningful symptom relief and modest body composition gains — not a 30-year-old's recomp curve.
Where Older Men Often Get Bad TRT Care
A few patterns to watch for, especially with low-cost online clinics:
Flat-dose prescribing without baseline labs. No clinic should start a 60-year-old on TRT without baseline PSA, hematocrit, and a metabolic panel.
AI co-prescribed from day one. Almost never the right call after 50.
Once-weekly injections as the default protocol. Workable for some, but produces more side-effect risk than twice-weekly in older men.
No PSA monitoring at 6 and 12 months. Standard of care, not optional.
Push to higher doses ("optimize" total T above 1000 ng/dL). Replacement is the goal, not supraphysiologic levels.
The TRT clinic red flags article catalogs the recurring patterns. For older men specifically, prefer clinics that:
Run full baseline labs including PSA before prescribing
Default to twice-weekly or subcutaneous protocols
Recheck labs at 6-8 weeks
Will adjust dose downward when hematocrit climbs (not just prescribe more phlebotomy)
The best online TRT clinics 2026 ranking weights monitoring rigor heavily — that matters more for older patients than for 30-year-olds.
Lifestyle Factors That Punch Above Their Weight
A few non-protocol items that disproportionately affect TRT outcomes after 50:
Sleep. Untreated sleep apnea worsens hematocrit, worsens blood pressure, and blunts TRT symptom benefit. A home sleep study is cheap. The TRT and sleep apnea article covers screening.
Resistance training. Older men who lift retain more of TRT's body-composition benefit. The TRT exercise training guide outlines a minimum-effective program.
Protein intake. Sarcopenia accelerates after 50. TRT plus 1.2-1.6 g/kg/day of protein outperforms TRT alone for lean mass retention.
Alcohol. Moderate alcohol raises aromatization and accelerates hematocrit. Heavy drinking blunts TRT's mood and energy benefits. TRT and alcohol has the detail.
Bottom Line
TRT after 50 is not a different therapy. It is the same therapy with tighter monitoring and a slower hand on the dose dial. The biggest mistakes older men make on TRT are not getting started — they are getting started on a protocol that fits a 30-year-old, with a clinic that does not monitor labs. Start lower, monitor more often, watch hematocrit and PSA closely, and resist the pull toward supraphysiologic doses. The TRAVERSE-era evidence supports TRT as safe in this population when those guardrails are in place.
This content is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting any treatment.
Frequently Asked Questions
Is TRT safe for men over 50?
Most evidence — including the TRAVERSE trial of 5,246 men aged 45-80 — shows TRT is safe for older men when total testosterone is replaced into the normal range and labs are monitored. Risk shifts with age: hematocrit rises faster, prostate monitoring matters more, and dose tolerance is generally lower than in younger men. The protocol changes, not the legitimacy.
What is the typical TRT dose for a man over 50?
Many older men do well on 80-120 mg per week of testosterone cypionate or enanthate, split twice weekly. That is usually lower than the 120-160 mg/week median seen in men in their 30s. Lower SHBG, slower clearance, and tighter hematocrit ceilings push the optimal dose down for many men in their 50s and 60s.
Does TRT cause prostate cancer in older men?
Current evidence does not show TRT increases prostate cancer incidence in men with no prior history. The TRAVERSE trial and multiple meta-analyses found no significant increase in prostate cancer rates among men on TRT versus placebo. PSA is still monitored, but the 'testosterone causes prostate cancer' framing from the 1940s has not held up in modern data.
How often should an older man on TRT get blood work?
A common schedule for men over 50 is baseline labs, recheck at 6-8 weeks after starting or after any dose change, then every 3 months for the first year, then every 6 months once stable. Hematocrit and PSA get the closest watch — both rise more readily with age.
Can a 65 or 70-year-old start TRT?
Yes. Age alone is not a contraindication. Older men with confirmed low testosterone and symptoms can start TRT, often at conservative doses (60-100 mg/week) with closer monitoring of hematocrit, blood pressure, and PSA. The Testosterone Trials demonstrated symptom benefit in men 65+ with low total T and symptoms.
